Rat hepatitis E virus (Rocahepevirus ratti) exposure in cats and dogs, Hong Kong

Estie Hon-Kiu Shun,Jianwen Situ,James Yiu-Hung Tsoi,Shusheng Wu,Jianpiao Cai,Kelvin Hon-Yin Lo,Nicholas Foo-Siong Chew,Zhiyu Li,Rosana Wing-Shan Poon,Jade Lee-Lee Teng,Vincent Chi-Chung Cheng,Kwok-Yung Yuen,Siddharth Sridhar
DOI: https://doi.org/10.1080/22221751.2024.2337671
2024-03-29
Emerging Microbes & Infections
Abstract:Hepatitis E virus (HEV) variants infecting humans belong to two species: <i>Paslahepevirus balayani</i> (bHEV) and <i>Rocahepevirus ratti</i> (rat hepatitis E virus; rHEV). <i>R. ratti</i> is a ubiquitous rodent pathogen that has recently been recognized to cause hepatitis in humans. Transmission routes of rHEV from rats to humans are currently unknown. In this study, we examined rHEV exposure in cats and dogs to determine if they are potential reservoirs of this emerging human pathogen. Virus-like particle-based IgG enzymatic immunoassays (EIAs) capable of differentiating rHEV &amp; bHEV antibody profiles and rHEV-specific real-time RT-PCR assays were used for this purpose. The EIAs could detect bHEV and rHEV patient-derived IgG spiked in dog and cat sera. Sera from 751 companion dogs and 130 companion cats in Hong Kong were tested with these IgG enzymatic immunoassays (EIAs). Overall, 13/751 (1.7%) dogs and 5/130 (3.8%) cats were sero-reactive to HEV. 9/751 (1.2%) dogs and 2/130 (1.5%) cats tested positive for rHEV IgG, which was further confirmed by rHEV immunoblots. Most rHEV-seropositive animals were from areas in or adjacent to districts reporting human rHEV infection. Neither 881 companion animals nor 652 stray animals carried rHEV RNA in serum or rectal swabs. Therefore, we could not confirm a role for cats and dogs in transmitting rHEV to humans. Further work is required to understand the reasons for low-level seropositivity in these animals.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?
This paper mainly explores the exposure situation of Rat hepatitis E virus (RHEV) in cats and dogs in the Hong Kong region to determine if they could be potential reservoir hosts for this emerging human pathogen. Enzyme-linked immunosorbent assay (ELISA) and real-time reverse transcription polymerase chain reaction (RT-PCR) were used to detect antibodies and viral RNA in animal samples, distinguishing between RHEV and bHEV antibody characteristics. The study found that a small percentage (1.7% of dogs and 3.8% of cats) out of 751 dogs and 130 cats showed positive HEV antibodies, and a portion of them (1.2% of dogs and 1.5% of cats) tested positive for RHEV-specific antibodies, which were further confirmed by immunoblotting. Most of the RHEV-seropositive animals were from areas where human RHEV infections have been reported or their surrounding areas. However, no RHEV RNA was detected in blood or rectal swab samples from either companion animals or stray animals, thus cannot confirm the role of cats and dogs in RHEV transmission between humans. The study concluded that although cats and dogs may have low-level exposure to RHEV, it is currently unclear why there is low-level seropositivity in animals, and further research is needed to understand this phenomenon. Additionally, more evidence is required to determine whether animals serve as reservoir hosts and sources of transmission for RHEV.